← All trials
NCT04694248
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2021
- Primary completion
- Jun 30, 2024
- Completion date
- Dec 31, 2024
- First posted
- Jan 5, 2021
- Last posted
- Jan 5, 2021
- Enrollment
- 172
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Zhejiang UniversityLead sponsor
- Zhejiang UniversityReponsible party - principal investigator
- Zhejiang UniversityOverall official - principal investigator
- Ningbo No. 2 HospitalCollaborator
- Boston Scientific CorporationCollaborator
- Wenzhou Medical UniversityCollaborator
- The Central Hospital of Lishui CityCollaborator
- Zhejiang UniversityCollaborator
- Taizhou Enze HospitalCollaborator
- Taizhou Hospital of Zhejiang ProvinceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.